Table 3.
Serum biochemical parameters of control and trial groups.
| Treatment group | Serum creatinine (mg/dl) | Total serum protein (G/dl) | Blood urea nitrogen (mg/dl) | Serum AST (U/l) | Serum ALT (U/l) | Total bilirubin (mg/dl) |
|---|---|---|---|---|---|---|
| Normal control (saline 10 ml/kg) | 0.49 ± 0.09 | 5.54 ± 0.32 | 28.32 ± 0.96 | 24.68 ± 1.70 | 25.33 ± 0.82 | 0.54 ± 0.11 |
| Diabetes control (saline 10 ml/kg) | 1.002 ± 0.019∗∗∗ | 3.3 ± 0.09∗∗∗ | 36.46 ± 0.35∗∗∗ | 29.54 ± 0.35∗∗∗ | 34.48 ± 0.36∗∗∗ | 0.71 ± 0.04∗∗∗ |
| Alzheimer's control (saline 10 ml/kg) | 0.30 ± 0.02∗∗∗ | 5.50 ± 0.27NS | 20.40 ± 2.30NS | 24.12 ± 1.46NS | 22.04 ± 1.48∗∗ | 0.46 ± 0.02∗∗∗ |
| Glibenclamide (10 mg/kg) | 0.42 ± 0.04NS | 5.92 ± 0.06∗ | 21.42 ± 0.38NS | 26.18 ± 0.52NS | 22.55 ± 0.30∗∗ | 0.35 ± 0.03∗∗∗ |
| Rivastigmine (10 mg/kg) | 1.84 ± 0.11∗∗∗ | 7.76 ± 0.30∗∗∗ | 21.00 ± 2.00NS | 64.90 ± 2.51∗∗∗ | 49.38 ± 1.04∗∗∗ | 1.06 ± 0.03∗∗∗ |
| Seed extract (100 mg/kg) | 0.23 ± 0.03∗∗∗ | 3.23 ± 0.02∗∗∗ | 9.06 ± 0.51∗∗∗ | 18.84 ± 0.62∗∗∗ | 20.88 ± 1.61∗∗∗ | 0.12 ± 0.01∗∗∗ |
| Seed extract (200 mg/kg) | 0.52 ± 0.05NS | 4.23 ± 0.02∗∗∗ | 15.8 ± 1.30∗∗∗ | 26.76 ± 0.71NS | 30.94 ± 1.66∗∗∗ | 0.22 ± 0.02∗∗∗ |
| Seed extract (400 mg/kg) | 0.83 ± 0.04∗∗∗ | 6.23 ± 0.02∗∗∗ | 25.40 ± 1.81∗∗∗ | 34.76 ± 0.71∗∗∗ | 40.88 ± 1.61∗∗∗ | 0.54 ± 0.03NS |
Data are expressed as mean ± SEM with significant levels of ∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05, and NS are nonsignificant compared to the normal control group where ALT and AST represent alanine aminotransferase and aspartate aminotransferase, respectively.